Detalhe da pesquisa
1.
Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer.
J Cancer Res Clin Oncol
; 149(19): 17123-17131, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768380
2.
Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer.
In Vivo
; 37(5): 2229-2236, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652490
3.
Lung Cancer Versus "Young Cancer": Is Non-Small Cell Lung Cancer in Young Patients a Different Entity?
J Adolesc Young Adult Oncol
; 11(5): 451-458, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726512
4.
Can Previous Chemotherapy Affect the Outcome of Nivolumab Treatment in Non-small Cell Lung Cancer?
Anticancer Res
; 42(4): 1987-1995, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347019
5.
Real-life Effectiveness of Afatinib Versus Gefitinib in Patients With Non-small-cell Lung Cancer: A Czech Multicentre Study.
Anticancer Res
; 41(4): 2059-2065, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33813414
6.
Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment.
Anticancer Res
; 41(5): 2597-2603, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33952489
7.
Prognostic Value of EGFR Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer.
Anticancer Res
; 41(11): 5625-5634, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34732435
8.
Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial.
Cancer Treat Res Commun
; 28: 100427, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34284344
9.
Real-life effectiveness of first-line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry.
Thorac Cancer
; 11(11): 3346-3356, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33016001
10.
Non-small Cell Lung Cancer as a Chronic Disease - A Prospective Study from the Czech TULUNG Registry.
In Vivo
; 34(1): 369-379, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31882501
11.
Care of patients with non-small-cell lung cancer stage III - the Central European real-world experience.
Radiol Oncol
; 54(2): 209-220, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32463394
12.
Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer.
Anticancer Res
; 38(12): 6771-6782, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30504389
13.
Carboplatin with intravenous and subsequent oral administration of vinorelbine in resected non-small-cell-lung cancer in real-world set-up.
PLoS One
; 12(7): e0181803, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28732018
14.
Lung cancer, pulmonary emphysema and pleural effusion: An autopsy study.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
; 159(4): 642-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26000874
15.
Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results.
J Thorac Oncol
; 3(2): 152-7, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18303436
16.
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.
Lancet Oncol
; 7(9): 719-27, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16945766